These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29137302)

  • 21. Establishment and validation of an AJCC stage- and histologic grade-based nomogram for pancreatic neuroendocrine tumors after surgical resection.
    Zhang C; Wu Y; Zhuang H; Li D; Lin Y; Yin Z; Lu X; Hou B; Jian Z
    Cancer Manag Res; 2019; 11():7345-7352. PubMed ID: 31496796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Consideration of Age Is Necessary for Increasing the Accuracy of the AJCC TNM Staging System of Pancreatic Neuroendocrine Tumors.
    Wang Z; Jiang W; Zheng L; Yan J; Dai J; Huang C; Zhang Q; Yin Z; Gong X; Zhang Y
    Front Oncol; 2019; 9():906. PubMed ID: 31608226
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms.
    Zhang Y; Shang L; Zhang PP; Chen LH; Wang W; Fang C; Qiu M; Feng XY; Zhou L; Zhang M; Tan HY; Qiu XD; Wang H; Lin R; Zhang Q; Zeng YJ; Jin KZ; Yu XJ; Shen L; Chen MH; Li J; Li LP; Chen J
    Cancer Med; 2019 Sep; 8(11):5000-5011. PubMed ID: 31293053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the seventh edition of the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical centre in Korea.
    Kim KH; Yang SS; Yoon YS; Lim SB; Yu CS; Kim JC
    Colorectal Dis; 2011 Aug; 13(8):e220-6. PubMed ID: 21689314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients.
    Scarpa A; Mantovani W; Capelli P; Beghelli S; Boninsegna L; Bettini R; Panzuto F; Pederzoli P; delle Fave G; Falconi M
    Mod Pathol; 2010 Jun; 23(6):824-33. PubMed ID: 20305616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors.
    Liu TC; Hamilton N; Hawkins W; Gao F; Cao D
    Am J Surg Pathol; 2013 Jun; 37(6):853-9. PubMed ID: 23598967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TNM Staging and Overall Survival in Patients With Pheochromocytoma and Sympathetic Paraganglioma.
    Jimenez C; Ma J; Roman Gonzalez A; Varghese J; Zhang M; Perrier N; Habra MA; Graham P; Waguespack SG
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1132-1142. PubMed ID: 36433823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reassessment of the current American Joint Committee on Cancer staging system for pancreatic neuroendocrine tumors.
    Qadan M; Ma Y; Visser BC; Kunz PL; Fisher GA; Norton JA; Poultsides GA
    J Am Coll Surg; 2014 Feb; 218(2):188-95. PubMed ID: 24321190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A single institution's 21-year experience with surgically resected pancreatic neuroendocrine tumors: an analysis of survival and prognostic factors.
    Cienfuegos JA; Rotellar F; Salguero J; Ruiz-Canela M; Núñez Córdoba JM; Sola I; Benito A; Martí-Cruchaga P; Zozaya G; Pardo F; Hernández Lizoáin JL
    Rev Esp Enferm Dig; 2016 Nov; 108(11):689-696. PubMed ID: 27701882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumors.
    Wang H; Ding D; Qin T; Zhang H; Liu J; Zhao J; Wu CH; Javed A; Wolfgang C; Guo S; Chen Q; Zhao W; Shi W; Zhu F; Guo X; Li X; Peng F; He R; Xu S; Jin J; Wu Y; Nuer A; Edil B; Tien YW; Jin G; Zheng L; He J; Liu J; Liu Y; Wang M; Qin R;
    HPB (Oxford); 2022 May; 24(5):681-690. PubMed ID: 34836754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which Staging System Is More Suitable for Gastric Neuroendocrine Cancer and Mixed Adenoneuroendocrine Carcinomas? A Multicenter Cohort Study.
    Lin J; Zhao Y; Zhou Y; Hao H; He Q; Tian Y; Zou B; Zhao G; Qiu X; Jiang L; Li Z; Xu Y; Xue F; Fu W; Xu Z; Li Y; Li S; Chen J; Zhou X; Zhu Z; Li H; Li Y; Li E; Cai L; Jia G; Xie JW; Li P; Zheng CH; Huang CM
    Neuroendocrinology; 2021; 111(11):1130-1140. PubMed ID: 31940636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the seventh edition of the American Joint Committee on Cancer tumour-node-metastasis (TNM) staging system for patients undergoing curative resection of hepatocellular carcinoma: implications for the development of a refined staging system.
    Chan AC; Fan ST; Poon RT; Cheung TT; Chok KS; Chan SC; Lo CM
    HPB (Oxford); 2013 Jun; 15(6):439-48. PubMed ID: 23659567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simple morphological classification to estimate the malignant potential of pancreatic neuroendocrine tumors.
    Oba A; Kudo A; Akahoshi K; Kishino M; Akashi T; Katsuta E; Iwao Y; Ono H; Mitsunori Y; Ban D; Tanaka S; Eishi Y; Tateishi U; Tanabe M
    J Gastroenterol; 2017 Oct; 52(10):1140-1146. PubMed ID: 28488114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters.
    Niederle MB; Hackl M; Kaserer K; Niederle B
    Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rethinking the Current American Joint Committee on Cancer TNM Staging System for Medullary Thyroid Cancer.
    Adam MA; Thomas S; Roman SA; Hyslop T; Sosa JA
    JAMA Surg; 2017 Sep; 152(9):869-876. PubMed ID: 28636692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Confirmation of the eighth edition of the AJCC/UICC TNM staging system for HPV-mediated oropharyngeal cancer in Japan.
    Mizumachi T; Homma A; Sakashita T; Kano S; Hatakeyama H; Fukuda S
    Int J Clin Oncol; 2017 Aug; 22(4):682-689. PubMed ID: 28271391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.
    Ellison TA; Wolfgang CL; Shi C; Cameron JL; Murakami P; Mun LJ; Singhi AD; Cornish TC; Olino K; Meriden Z; Choti M; Diaz LA; Pawlik TM; Schulick RD; Hruban RH; Edil BH
    Ann Surg; 2014 Feb; 259(2):204-12. PubMed ID: 23673766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis.
    Li X; Gou S; Liu Z; Ye Z; Wang C
    Cancer Med; 2018 Mar; 7(3):626-634. PubMed ID: 29380547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.